These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30105630)

  • 1. Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ratio in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.
    Tsukioka T; Izumi N; Mizuguchi S; Kyukwang C; Komatsu H; Toda M; Hara K; Miyamoto H; Nishiyama N
    Gen Thorac Cardiovasc Surg; 2018 Dec; 66(12):716-722. PubMed ID: 30105630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].
    Zhang S; Wang L; Lu F; Pei Y; Yang Y
    Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):702-708. PubMed ID: 31771739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
    Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
    Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
    Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
    J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
    Dirican N; Karakaya YA; Gunes S; Daloglu FT; Dirican A
    Clin Respir J; 2017 Nov; 11(6):789-796. PubMed ID: 26619201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer.
    Cannon NA; Meyer J; Iyengar P; Ahn C; Westover KD; Choy H; Timmerman R
    J Thorac Oncol; 2015 Feb; 10(2):280-5. PubMed ID: 25299234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.
    Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Morita S; Kawamura M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1324-31. PubMed ID: 26198075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients 
Treated with Surgery].
    Yang H; Dai L; Li P; Shen L; Yan W; Fan M; Chen K
    Zhongguo Fei Ai Za Zhi; 2015 Aug; 18(8):505-11. PubMed ID: 26302348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.
    Tsukioka T; Izumi N; Kyukwang C; Komatsu H; Toda M; Hara K; Nishiyama N
    Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):121-126. PubMed ID: 29459570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers?
    Kacan T; Babacan NA; Seker M; Yucel B; Bahceci A; Eren AA; Eren MF; Kilickap S
    Asian Pac J Cancer Prev; 2014; 15(5):2089-94. PubMed ID: 24716939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer.
    Sarraf KM; Belcher E; Raevsky E; Nicholson AG; Goldstraw P; Lim E
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):425-8. PubMed ID: 19185164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment.
    Lin GN; Peng JW; Liu PP; Liu DY; Xiao JJ; Chen XQ
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e189-e194. PubMed ID: 25359280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.